Ashley Sconzo

Clinical Research Manager at Milestone Pharmaceuticals - Montreal, QC, US

Ashley Sconzo's Contact Details
HQ
514-336-0444
Location
Charlotte, North Carolina, United States
Company
Milestone Pharmaceuticals
Ashley Sconzo's Company Details
Milestone Pharmaceuticals logo, Milestone Pharmaceuticals contact details

Milestone Pharmaceuticals

Montreal, QC, US • 50 - 99 Employees
BioTech/Drugs

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by Milestone and being developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of PSVT as they occur. Milestone is actively recruiting patients for a Phase 3 clinical trial of etripamil for the treatment of PSVT. Milestone plans to initiate a Phase 2 clinical trial in atrial fibrillation, another rapid heart rate condition, and expects to subsequently initiate an additional Phase 2 clinical trial in angina to establish proof-of-concept for the broader use of etripamil.

B2B Biotechnology Cleantech Healthcare Pharmaceuticals Wind Power Biotech Biotech
Details about Milestone Pharmaceuticals
Frequently Asked Questions about Ashley Sconzo
Ashley Sconzo currently works for Milestone Pharmaceuticals.
Ashley Sconzo's role at Milestone Pharmaceuticals is Clinical Research Manager.
Ashley Sconzo's email address is ***@milestonepharma.com. To view Ashley Sconzo's full email address, please signup to ConnectPlex.
Ashley Sconzo works in the BioTech/Drugs industry.
Ashley Sconzo's colleagues at Milestone Pharmaceuticals are Harish Pimplaskar, Nicole DeVirgiliis, Lorenz Muller, Miguel Romero Sepúlveda, Natacha Saint-Lary, David Rowe, Francis Plat and others.
Ashley Sconzo's phone number is 514-336-0444
See more information about Ashley Sconzo